Regeneron Study Site

Tulsa, Oklahoma

We've found

1 trials

at this facility

Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Tulsa, OK

Use our guide to learn which trials are right for you!